Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination
12 sept. 2022 09h15 HE
|
Aesther Healthcare Acquisition Corp.
New York, NY and Providence, RI, Sept. 12, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 30, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into...
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital
08 sept. 2022 08h07 HE
|
Aesther Healthcare Acquisition Corp.
NEWS PROVIDED BY Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) September 8, 2022, 07:45 am ET NEW YORK and PROVIDENCE, R.I., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition...
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA)
06 sept. 2022 07h59 HE
|
Ocean Biomedical, Inc.
Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol, “OCEA”....
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA)
06 sept. 2022 07h45 HE
|
Aesther Healthcare Acquisition Corp.
• Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol,...
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
31 août 2022 07h47 HE
|
Aesther Healthcare Acquisition Corp.
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.Ocean...
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
31 août 2022 07h45 HE
|
Ocean Biomedical, Inc.
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.Ocean...
Aesther Healthcare Acquisition Corp. Announces Separate Trading of its Class A Common Stock and Warrants to Commence on November 5, 2021
03 nov. 2021 16h35 HE
|
Aesther Healthcare Acquisition Corp.
NEW YORK, NY, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) today announced that, commencing November 5, 2021, holders of the units sold in...
Aesther Healthcare Acquisition Corp. Announces Closing of Initial Public Offering and Partial Exercise of Over-Allotment Option
17 sept. 2021 13h30 HE
|
Aesther Healthcare Acquisition Corp.
New York, NY, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) announced today the closing of its initial public offering of 10,000,000 units...
Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering
10 juin 2021 08h59 HE
|
Ocean Biomedical, Inc.
PROVIDENCE, R.I., June 10, 2021 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (“Ocean”) today announced that it has publicly filed a Registration Statement on Form S-1 (the “Registration Statement”)...